These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38290689)

  • 1. Pulmonary RNA interference against acute lung injury mediated by mucus- and cell-penetrating nanocomplexes.
    Zhang W; Shen J; Liang J; Ge C; Zhou Y; Yin L; Ji Y
    Acta Biomater; 2024 Mar; 177():332-346. PubMed ID: 38290689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-targeting and reactive oxygen species (ROS)-responsive nanopolyplexes mediate anti-inflammatory siRNA delivery against acute liver failure (ALF).
    Zhang W; Zhou Y; Li X; Xu X; Chen Y; Zhu R; Yin L
    Biomater Sci; 2018 Jun; 6(7):1986-1993. PubMed ID: 29855002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorinated α-Helical Polypeptides Synchronize Mucus Permeation and Cell Penetration toward Highly Efficient Pulmonary siRNA Delivery against Acute Lung Injury.
    Ge C; Yang J; Duan S; Liu Y; Meng F; Yin L
    Nano Lett; 2020 Mar; 20(3):1738-1746. PubMed ID: 32039603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface Coating of Pulmonary siRNA Delivery Vectors Enabling Mucus Penetration, Cell Targeting, and Intracellular Radical Scavenging for Enhanced Acute Lung Injury Therapy.
    Zhu J; Guo M; Cui Y; Meng Y; Ding J; Zeng W; Zhou W
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):5090-5100. PubMed ID: 35060376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Membrane-Reversibly Cloaked Nanotherapeutics for the Anti-Inflammatory and Antioxidant Treatment of Rheumatoid Arthritis.
    Shan B; Zhou Y; Yin M; Deng Y; Ge C; Liu Z; Zhou R; Dong Q; Zhou X; Yin L
    Small Methods; 2023 Sep; 7(9):e2300667. PubMed ID: 37469217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles.
    He H; Zheng N; Song Z; Kim KH; Yao C; Zhang R; Zhang C; Huang Y; Uckun FM; Cheng J; Zhang Y; Yin L
    ACS Nano; 2016 Feb; 10(2):1859-70. PubMed ID: 26811880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pillar arene Se nanozyme therapeutic systems with dual drive power effectively penetrated mucus layer combined therapy acute lung injury.
    Chen X; Yang Y; Mai Q; Ye G; Liu Y; Liu J
    Biomaterials; 2024 Jan; 304():122384. PubMed ID: 38016334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assisted membrane-penetrating helical polypeptides mediate anti-inflammatory RNAi against myocardial ischemic reperfusion (IR) injury.
    Liang Q; Li F; Li Y; Liu Y; Lan M; Wu S; Wu X; Ji Y; Zhang R; Yin L
    Biomater Sci; 2019 Aug; 7(9):3717-3728. PubMed ID: 31187803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Inflammatory Effect of Anti-TNF-α SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model.
    Bohr A; Tsapis N; Andreana I; Chamarat A; Foged C; Delomenie C; Noiray M; El Brahmi N; Majoral JP; Mignani S; Fattal E
    Biomacromolecules; 2017 Aug; 18(8):2379-2388. PubMed ID: 28639789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA Nanoparticle Dry Powder Formulation with High Transfection Efficiency and Pulmonary Deposition for Acute Lung Injury Treatment.
    Xu R; Xia C; He X; Hu C; Li Y; Zhang Y; Chen Z
    ACS Appl Mater Interfaces; 2024 Oct; 16(40):54344-54358. PubMed ID: 39325628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zn-dipicolylamine-based reactive oxygen species-responsive lipids for siRNA delivery and in vivo colitis treatment.
    Guo Y; He X; Zhao RM; Yang HZ; Huang Z; Zhang J; Yu XQ
    Acta Biomater; 2022 Jul; 147():287-298. PubMed ID: 35489607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice.
    Wang WT; Zhang YY; Li ZR; Li JM; Deng HS; Li YY; Yang HY; Lau CC; Yao YJ; Pan HD; Liu L; Xie Y; Zhou H
    Phytomedicine; 2024 Jul; 129():155591. PubMed ID: 38692075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blockade of programmed death-ligand 1 attenuates indirect acute lung injury in mice through targeting endothelial cells but not epithelial cells].
    Sun B; Li X; Zheng G; Dong T; Li Y; Li H; Yan Y; Bai J; Xu S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):37-43. PubMed ID: 30707867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery.
    Baldassi D; Ngo TMH; Merkel OM
    Pharm Res; 2024 Jan; 41(1):77-91. PubMed ID: 36447020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.
    Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W
    Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
    Merckx P; De Backer L; Van Hoecke L; Guagliardo R; Echaide M; Baatsen P; Olmeda B; Saelens X; Pérez-Gil J; De Smedt SC; Raemdonck K
    Acta Biomater; 2018 Sep; 78():236-246. PubMed ID: 30118853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal Macrophage-Specific TNF-α Gene Silencing in LPS-Induced Acute Inflammation Model Using CD44 Targeting Hyaluronic Acid Nanoparticles.
    Kosovrasti VY; Nechev LV; Amiji MM
    Mol Pharm; 2016 Oct; 13(10):3404-3416. PubMed ID: 27552547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.
    Wang Y; Ding L; Li Z; Chen G; Sun M; Oupicky D
    J Control Release; 2019 Nov; 314():12-24. PubMed ID: 31644934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
    Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
    Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
    He C; Yin L; Song Y; Tang C; Yin C
    Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.